Skip to content

ARMATA PHARMACEUTICALS, INC.: filings

Every ARMATA PHARMACEUTICALS, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 54 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q2 2026401050001104659-26-094907
10-Q2026-05-13fiscal Q1 202639820001104659-26-060333
10-K2026-03-25fiscal FY 202540810001104659-26-034532
10-Q2025-11-12fiscal Q3 2025401080001104659-25-110383
10-Q2025-08-12fiscal Q2 2025401080001558370-25-011235
10-Q2025-05-14fiscal Q1 202540840001558370-25-007765
10-K2025-03-21fiscal FY 202441830001558370-25-003406
10-Q2024-11-13fiscal Q3 2024401080001558370-24-015530
10-Q2024-08-13fiscal Q2 2024421140001558370-24-012061
10-Q2024-05-07fiscal Q1 202441850001558370-24-007068
10-K2024-03-21fiscal FY 202341860001558370-24-003706
10-Q2023-11-14fiscal Q3 2023391080001558370-23-019036
10-Q2023-08-14fiscal Q2 2023371040001558370-23-014701
10-Q2023-05-11fiscal Q1 202338820001558370-23-009372
10-K2023-03-16fiscal FY 202242890001558370-23-004014
10-Q2022-11-09fiscal Q3 2022381030001558370-22-017141
10-Q2022-08-11fiscal Q2 2022381010001558370-22-013269
10-Q2022-05-12fiscal Q1 202238800001558370-22-008532
10-K2022-03-17fiscal FY 202142870001558370-22-003845
10-Q2021-11-10fiscal Q3 202134890001558370-21-015483
10-Q2021-08-12fiscal Q2 202134890001558370-21-011476
10-Q2021-05-13fiscal Q1 202134730001558370-21-007070
10-K2021-03-18fiscal FY 202043880001558370-21-003202
10-Q2020-11-12fiscal Q3 2020381050001558370-20-013695
10-Q2020-08-13fiscal Q2 202035930001558370-20-010541
10-Q2020-05-14fiscal Q1 202032670001558370-20-006601
10-K2020-03-19fiscal FY 201944820001558370-20-002943
10-Q2019-11-12fiscal Q3 201937990001558370-19-010811
10-Q2019-08-14fiscal Q2 201937990001558370-19-008168
10-Q2019-05-06fiscal Q1 201931610001144204-19-023904
10-K2019-03-25fiscal FY 201835720001144204-19-015711
10-Q2018-11-08fiscal Q3 201835910001144204-18-058340
10-Q2018-08-09fiscal Q2 201835930001144204-18-043320
10-Q2018-05-15fiscal Q1 201829580001144204-18-028870
10-K2018-03-14fiscal FY 201736740001144204-18-014652
10-Q2017-11-14fiscal Q3 201732850001144204-17-059027
10-Q2017-08-14fiscal Q2 201733900001144204-17-043154
10-Q2017-05-15fiscal Q1 201727550001144204-17-027450
10-K2017-03-27fiscal FY 2016341210001144204-17-016833
10-Q2016-11-10fiscal Q3 201632900001144204-16-133271
10-Q2016-08-15fiscal Q2 201632900001144204-16-119427
10-Q2016-05-12fiscal Q1 201631660001144204-16-101268
10-K2016-03-30fiscal FY 2015351340001144204-16-091546
10-Q2015-11-16fiscal Q3 201531880001144204-15-066161
10-Q2015-08-13fiscal Q2 201531860001144204-15-049053
10-Q2015-05-15fiscal Q1 201526560001144204-15-031520
10-K2015-04-15fiscal FY 201432660001144204-15-023071
10-Q/A2015-04-15fiscal Q3 201432960001144204-15-023068
10-Q/A2015-04-15fiscal Q2 201432920001144204-15-023067
10-Q/A2015-04-15fiscal Q1 201427700001144204-15-023064
10-Q2014-11-14fiscal Q3 201432900001144204-14-068950
10-Q2014-09-12fiscal Q2 201432900001144204-14-055691
10-Q2014-09-12fiscal Q1 201427690001144204-14-055681
10-Q2014-05-20fiscal Q1 201428720001144204-14-032483

Inspect the source

Entity
ARMATA PHARMACEUTICALS, INC. / CIK 0000921114
Captured
2026-09-20T05:08:00.156Z
SEC response SHA-256
e2bc0c6fd82f16eeba84a16462f0828ac4ed107fd97a134be631976d00a341c5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000921114.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))